Protalix BioTherapeutics (PLX) Tops Q1 EPS by 40c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- US stocks set for higher open as AI trade steadies; midterms in focus
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops more than 4% on talks aimed at ending US-Iran war
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
| PROTALIX BIOTHERAPEUTICS, INC. COMMON STOCK (NYSE: PLX) | Delayed: 2.59 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.59 | 52 Week High | $1.11 | |||
| Open | $2.59 | 52 Week Low | $0.41 | |||
| Day High | $2.59 | P/E | N/A | |||
| Day Low | $2.59 | EPS | $-0.29 | |||
| Volume | 1,858 | |||||
